ClinicalTrials.govpublic full text
Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor
multiple sclerosis (ms) - relapsing-remitting, relapsing-remitting ms, nonresponsive to standard of care ms, sirolimus, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 891370
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.